Stirred-Tank Bioreactor Sensor Patents: Leaders & White Space 2026
Stirred-Tank Bioreactor Sensor Integration Patents
Filing peaked in 2022 at 17 records then eased off — a pattern more consistent with a claims plateau than a cooling field, since publication lag understates the most recent years. Filings rose from 2 records in 2017 to a peak of 17 in 2022, the single busiest year in the dataset. 2026 figures are partial because the data cut-off falls mid-year and recent filings have not all published yet, so the true trajectory beyond 2022 is not yet fully visible.
- 1OCTANE BIOTECH INC21
- 2CELLINO BIOTECH INC21
- 3THE AUTOMATION PARTNERSHIP (CAMBRIDGE) LTD13
- 4LONZA WALKERSVILLE INC12
- 5LONZA COLOGNE AG9
See the full stirred-tank bioreactor sensor integration analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions on this landscape
Who holds the most patents in stirred-tank bioreactor sensor integration?
One assignee leads the ranked list with 21 records, well ahead of the field — fifth place holds only 9 and tenth place just 2. That drop-off indicates a concentrated core of early, foundational filings around single-use and automated stirred-tank platforms rather than many companies holding roughly equal shares. Reviewing that leader’s claim scope closely is the most useful starting point before filing anything adjacent.
Is the stirred-tank bioreactor sensor patent field still active?
Filing rose from 2 records in 2017 to a peak of 17 in 2022, then appears to ease off in the years since. Because publication typically lags filing by around 18 months, the apparent decline after 2022 is likely overstated — some of those years will fill in as pending applications publish. Treat the post-2022 numbers as provisional rather than a confirmed slowdown.
What technology areas dominate the IPC classification of these patents?
C12M (bioreactors and enzyme apparatus) appears in 98.9% of the 93 records in scope, essentially universal given the search scope, and C12N (microorganisms and genetic engineering) reaches 60.2%, reflecting how often sensor claims are bundled with cell-culture process claims. By contrast, B01F (mixing and stirring) sits at just 4.3% and B01L (lab apparatus) at 20.4%, both comparatively thin given how central agitation is to the hardware. That imbalance is a useful signal for where claim space remains lighter.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Stirred-Tank Bioreactor Sensor Integration covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.